Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and... see more

Recent & Breaking News (OTCPK:AAQL)

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions

GlobeNewswire October 24, 2019

ACHILLION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Achillion Pharmaceuticals, Inc. - ACHN

Business Wire October 24, 2019

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - CISN, IPHS, ACHN

ACCESSWIRE IA October 24, 2019

MERGER ALERT - ACHN, JAG, and ROAN: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies

GlobeNewswire October 23, 2019

ACHN, ROAN, VSI: Monteverde & Associates PC Reminds Investors of its Ongoing Investigation Regarding the Merger

ACCESSWIRE IA October 23, 2019

Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - IPHS, ACHN, RARX, TSG

GlobeNewswire October 22, 2019

INVESTOR ALERT: Monteverde & Associates PC Is Investingating The Merger

ACCESSWIRE IA October 19, 2019

SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.

PR Newswire October 18, 2019

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - RARX, DOVA, ACHN

ACCESSWIRE IA October 18, 2019

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on Behalf of Achillion Shareholders and Encourages Achillion Investors to Contact the Firm

PR Newswire October 17, 2019

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Achillion Pharmaceuticals, Inc. (NASDAQ GS: ACHN)

ACCESSWIRE IA October 16, 2019

ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

ACCESSWIRE IA October 16, 2019

ACHILLION MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Achillion Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - ACHN

GlobeNewswire October 16, 2019

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Alexion Pharmaceuticals, Inc.

PR Newswire October 16, 2019

Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fair Deal?

PR Newswire October 16, 2019

Alexion to Acquire Achillion

Business Wire October 16, 2019

Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 26, 2019

Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria

GlobeNewswire September 25, 2019

Achillion to Present at the Baird 2019 Global Healthcare Conference

GlobeNewswire August 29, 2019

Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire August 8, 2019